Eli Lilly: The Bar Just Got Higher (NYSE:LLY)
· seekingalpha.com
Eli Lilly delivered standout 3Q26 results, with 39% revenue growth to $24.4B, driven by Mounjaro and Zepbound franchises. Read why LLY stock is a buy.
We recently saw pretty standout earnings results from Eli Lilly and Company ( LLY ). The stock also had a good reaction to the call and closed about 7% higher o...